ILMN
Illumina, Inc. · Healthcare · Diagnostics & Research
TECHStrong BuyZACKSBuy
R500#39 today
$273.04
+2.75% today · +1.13% 1W
Oct 2 close or latest
PreviewWhy it's moving
Outperforming without a clear catalyst yet
- ILMN +2.75% on the last session vs SPY +0.74%: +2.0 pts of stock-specific move.
- Aftermath, rsi overbought (Oct 2): After its 11 overbought readings in the past 5 years, ILMN typically gained 3.2% over the next month (median) and was higher 64% of the time; half the outcomes fell between -1.7% and +10.8%. An ordinary month: -0.1%. Among S&P 500 stocks after overbought readings, that ranks #117 of 501.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
ILMN against the S&P 500 components
| Window | Rank of 500 | Position | Gain | SPY gain |
|---|---|---|---|---|
| 1 day | #39 | +2.75% | +0.74% | |
| 1 week | #118 | +1.13% | -0.22% | |
| 1 month | #10 | +28.04% | +0.84% | |
| 3 months | #13 | +44.71% | +3.59% | |
| 6 months | #16 | +114.35% | +17.95% | |
| 1 year | #15 | +174.96% | +16.25% | |
| Overall | #9 | sum of the six window ranks, ranked again | ||
R500 ranks the stock's gain over each window against the S&P 500 components over the same window (#1 = best). Near-real-time during market hours.
Fundamentals Diagnostics & Research
| Metric | Value | Rank in S&P 500 | Rank in industry |
|---|---|---|---|
| Targeted Gain Median | -0.22 | #473 | #10 |
| fPE/tPE | 0.90 | #389 | #11 |
| PE/G | 3.37 | #437 | #12 |
| EV/Revenue | 9.48 | #74 | #2 |
| Gross Margin | 0.68 | #103 | #1 |
| Profit Margin | 0.18 | #173 | #4 |
| Revenue Growth | 0.09 | #244 | #5 |